Amazing product gammaCore (nVNS technology) that is FDA approved for certain treatments. At the moment it's a medical device painkiller without the use of medication/drug. Helps avoid many drug-like side effects and inconveniences associated with injectable, inhaled, or pill-based medicines.
The same product and technology is being extended to explore other areas:
www.electrocore.com/...velopments/pipeline/
Other Positives:
Positive financial guidance for next quarter:
Full-year 2020 Revenue: electroCore anticipates that full-year 2020 revenue will be at the upper end of the previously announced guidance range of $3.3 million to $3.5 million, representing greater than 40% growth over full-year 2019 revenue of $2.4 million.
(www.globenewswire.co...ancial-Guidance.html)
The same product and technology is being extended to explore other areas:
www.electrocore.com/...velopments/pipeline/
Other Positives:
- Scottish Health Technology recommendation (seekingalpha.com/new...for-cluster-headache)
- 5 Analysts buy (www.tipranks.com/stocks/ecor/forecast)
- Centers for Medicare and Medicaid Services (“CMS”) validation (www.globenewswire.co...erve-Stimulator.html)
Positive financial guidance for next quarter:
Full-year 2020 Revenue: electroCore anticipates that full-year 2020 revenue will be at the upper end of the previously announced guidance range of $3.3 million to $3.5 million, representing greater than 40% growth over full-year 2019 revenue of $2.4 million.
(www.globenewswire.co...ancial-Guidance.html)